The Scales for Outcomes in Parkinson’s disease-Psychiatric Complications (SCOPA-PC) is a validated tool to score psychotic and compulsive symptoms in Parkinson’s disease (PD). We translated into Italian the SCOPA-PC and evaluated its psychometric properties and clinical correlates in different subgroups of PD patients. The scale underwent translation, back-translation, and cognitive pretesting before being administered to a calculated sample of 135 PD patients. All patients underwent a clinical interview, motor evaluation, cognitive screening test, behavioral and functional scales. We explored SCOPA-PC feasibility, acceptability, internal consistency, convergent validity, known-groups validity, and test–retest reliability. The mean SCOPA-PC score was 1.99 ± 2.09. The internal consistency was acceptable (α = 0.631); corrected item-total correlation was > 0.45 for most items. The significant and moderate correlation of the SCOPA-PC with other tools evaluating psychiatric symptoms indicated adequate convergent validity of the scale. The factor analysis disclosed two factors, with total variance equal to 50.19%. The reliability of SCOPA-PC was high especially in cognitively preserved patients not on medications for dementia, depression, psychosis and anxiety. The SCOPA-PC is a rapid and reliable screening tool for assessing psychotic and compulsive symptoms in PD. Our data support a role for the SCOPA-PC as a screening scale in early, non-demented PD.

Psychometric properties of the Italian version of scale for outcomes in Parkinson’s disease psychiatric complications in Parkinson disease

Cuoco, Sofia;Cappiello, Arianna;Carotenuto, Immacolata;Bisogno, Rossella;Sorrentino, Cristiano;Barone, Paolo;Picillo, Marina
2025

Abstract

The Scales for Outcomes in Parkinson’s disease-Psychiatric Complications (SCOPA-PC) is a validated tool to score psychotic and compulsive symptoms in Parkinson’s disease (PD). We translated into Italian the SCOPA-PC and evaluated its psychometric properties and clinical correlates in different subgroups of PD patients. The scale underwent translation, back-translation, and cognitive pretesting before being administered to a calculated sample of 135 PD patients. All patients underwent a clinical interview, motor evaluation, cognitive screening test, behavioral and functional scales. We explored SCOPA-PC feasibility, acceptability, internal consistency, convergent validity, known-groups validity, and test–retest reliability. The mean SCOPA-PC score was 1.99 ± 2.09. The internal consistency was acceptable (α = 0.631); corrected item-total correlation was > 0.45 for most items. The significant and moderate correlation of the SCOPA-PC with other tools evaluating psychiatric symptoms indicated adequate convergent validity of the scale. The factor analysis disclosed two factors, with total variance equal to 50.19%. The reliability of SCOPA-PC was high especially in cognitively preserved patients not on medications for dementia, depression, psychosis and anxiety. The SCOPA-PC is a rapid and reliable screening tool for assessing psychotic and compulsive symptoms in PD. Our data support a role for the SCOPA-PC as a screening scale in early, non-demented PD.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11386/4944240
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact